Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Prediction of Sepsis by Metabolomic Pofiling in Critically Ill Patients

NCT03996759 is registered in ClinicalTrials.gov with Xi Peng as lead sponsor.

NCT NCT03996759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03996759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Prediction of Sepsis by Metabolomic Pofiling in Critically Ill Patients
Lead sponsor
Xi Peng
Phase
Observational
Overall status
Unknown status
Start date
July 10, 2019
Completion date
December 31, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis